![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 49, 51298-51304, December 3, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


From the Hormone and Metabolic Research Unit, Institute of Cellular Pathology and Université catholique de Louvain, 75 Avenue Hippocrate, B-1200 Brussels, Belgium
Received for publication, August 6, 2004 , and in revised form, September 13, 2004.
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Hepatocyte nuclear factor-6 (HNF-6) belongs to the Onecut (OC) family of transcription factors (5, 6). These factors possess a single cut domain, hence their name, and a divergent homeodomain, which are both involved in DNA binding. Onecut proteins have been identified not only in humans and rodents, but also in model organisms such as Caenorhabditis elegans (6), Drosophila melanogaster (7), and Danio rerio (8). In addition to Hnf6, mammalian genomes contain two other Onecut genes called Oc2 and Oc3 (9, 10). The sequence conservation in their cut and homeodomains suggests that these paralogs may bind the same genes, and indeed many HNF-6 binding sites on DNA are recognized by OC-2 and OC-3 (9, 10). During mouse development, HNF-6 is first detected at e8.5 in the foregut-midgut region. As development proceeds, HNF-6 becomes restricted to the liver and the pancreas (11, 12). Expression of Oc2 in the endoderm is superimposable to that of Hnf6 (13), and later on it is restricted to the liver, pancreas, gut, and stomach. Nothing is known on the endodermal expression of OC-3, but at later stages Oc3 is found in the gut and stomach (10). Thus, the three Onecut factors share partially overlapping expression domains and may be functionally redundant.
Inactivation of the mouse Hnf6 gene revealed that it is important for development of the pancreas at the precursor stage in the endoderm (14). Thus, Hnf6 knock-out embryos display a pancreatic hypoplasia that results from defects in early pancreas specification. Indeed, the onset of Pdx-1 expression is delayed in the endoderm of Hnf6 knock-out embryos, leading to a reduced number of specified cells in the pancreatic territory at the time of budding. Consistent with this, HNF-6 can bind to and stimulate transcription of the Pdx1 gene (14).
In the present work, we wished to further characterize the transcription factor network in the endoderm. We have examined the time course of expression of the three Onecut factors in the developing endoderm of normal mouse embryos and have investigated whether inactivation of Hnf6 influences the expression of Oc2 and Oc3. We show here that, in the endoderm of Hnf6 knock-out embryos, Oc2 expression is unaffected, but Oc3 expression is abolished. We demonstrate that HNF-6 can induce Oc3 expression and we provide evidence that this is a direct effect. Our work defines new stages in endoderm differentiation and identifies a paralogous regulatory cascade in the Onecut transcription factors, which operates during differentiation of the endoderm, liver, and pancreas.
| EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Dissection, RNA Purification, and Reverse Transcription-coupled PCRRNA was extracted from tissues with the Tripure RNA Isolation reagent (Roche Diagnostics). Individual embryos at the 514-somite stage were dissected in phosphate-buffered saline containing 1.5 mg/ml dispase (Invitrogen) to separate the endoderm layer from the mesoderm and ectoderm. Most of the endoderm, including the hindgut, midgut, and foregut regions, was used for RNA extraction. At e9.5 and e10.5, the region that gives rise to the liver, pancreas, part of the stomach, and gut was dissected from a single embryo. At e12.5, the pancreas or the liver were isolated. Total RNA from transfected cells or from embryos electroporated with plasmid DNA was treated with TURBO DNase I according to the manufacturer (Ambion), to eliminate DNA. Total RNA (up to 1 µg) was reverse transcribed as described (16). For semiquantitative PCR, the number of cycles for each pair of primers was such that amplification was in the mid-logarithmic phase. Quantitative real time PCR was performed with the SYBR Green PCR Core kit or master mixture (Eurogentec) on a MyIQ thermal cycler (Bio-Rad). Treshold cycles were transformed to copy number according to the standard calibration curve. Absolute copy number for each mRNA was normalized to absolute
-actin mRNA copy number. Primer sequences were 5'-TCCTGAGCGCAAGTACTCTGT-3' and 5'-CTGATCCACATCTGCTGGAAG-3' for
-actin, 5'-AGCCCTGGAGCAAACTCAAGT-3' and 5'-TGCATGTAGAGTTCGACGTTG-3' for exogenous HNF-6, 5'-TTCCAGCGCATGTCGGCGCTC-3' and 5'-GGTACTAGTCCGTGGTTCTTC-3' for endogenous HNF-6, 5'-GCATGTCTGCCTTACGCCTG-3' and 5'-GCGGGATTTCTTCTGCGAG-3' for OC-2, 5'-CGGAGTTCCAGCGCATGTC-3' and 5'-GAGAAGGTGGCAGTAGCTGTC-3' for OC-3, 5'-AAGAGCCCAACCGCGTCCAGC-3' and 5'-AGTACGGGTCCTCTTGTTTTC-3' for Pdx-1, 5'-CCTCGTGACCACCCTGAC-3' and 5'-CTCAGGTAGTGGTTGTCGG-3' for green fluorescent protein (GFP), 5'-TGAGGTCGACTGAGAGGTTC-3' and 5'-TGTGCCCCCTGAGCCCCAAG-3' for Oc3 region a, 5'-AAGTCTGGACAGTCTGCAAG-3' and 5'-TACCAGCCACCCCGGGATTC-3' for Oc3 region b, 5'-CAACCCTCTGCCCAGGAATC-3' and 5'-GCCAGGATCAGAGTCAAGTC-3' for Oc3 region c.
Antibodies and ImmunofluorescenceAnti-OC-3 antibodies were raised against the N-terminal moiety of mouse OC-3. Amino acids 23 to 333 of OC-3 were fused downstream of the glutathione S-transferase coding sequence in the pGEX-CS vector (17) and produced in Escherichia coli. The fusion protein was purified using glutathione and extracted from colloidal blue-stained SDS-PAGE before injection to guinea pigs. Their serum was used as a source of anti-OC-3 antibodies. For immunofluorescence, embryos were fixed at 4 °C in 4% paraformaldehyde in phosphate-buffered saline for 1 h. Embryos were embedded and immunofluorescence was detected as described (18). Primary antibodies and dilutions were as follows: monoclonal mouse anti-E-cadherin at 1:50 (BD Transduction Laboratories), rabbit anti-HNF-6 at 1:25 (Santa Cruz), rabbit anti-Pdx-1 at 1:1000 (a kind gift from C. V. Wright), rabbit anti-Prox1 at 1:1000 (Covance), and guinea pig anti-OC-3 at 1:4000. Primary antibodies were detected by immunofluorescence using biotinylated sheep anti-rabbit immunoglobulin G (Roche Diagnostics) followed by streptavidin-Alexa Fluor 488 conjugate (Molecular Probes), using a goat anti-mouse antibody coupled to Texas Red (Jackson) or using a goat anti-guinea pig antibody coupled to Alexa Fluor 594 (Molecular Probes). Sections were analyzed with a Zeiss Axiovert 200 fluorescence microscope. For immunohistochemistry, primary antibodies were detected by immunoperoxidase labeling using biotinylated sheep anti-rabbit or anti-guinea pig immunoglobulin G (Jackson ImmunoResearch) and DAB+ (Dako). Pictures were taken using a Coolpix 995 digital camera (Nikon).
Cell Culture and TransfectionsBipotential embryonic mouse liver (BMEL) cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, insulin-like growth factor II, insulin, and EGF according to Strick-Marchand and colleagues (19, 20). The cells were transfected, using LipofectAMINE 2000, in 6-well plates for 24 h with 6 µg of the CMV promoter-driven pcDNA3-EGFP (Invitrogen), pCMV-Flag/HNF-6, or pCMV-Flag/HNF-6-VP16 expression vectors. To perform chromatin immunoprecipitation cells were transfected in 10-cm dishes for 26 h with 15 µg of the pCMV-Flag/HNF-6 expression vector.
Protein Extraction and Western BlottingProtein extraction was performed according to the manufacturer's instructions on the same samples from which RNA was isolated with the Tripure reagent. Equal volumes were loaded on SDS-PAGE gels, as protein concentration could not be measured. Western blotting was performed as described (21) with anti-GFP (Molecular Probes) or anti-FLAG (M2, Sigma) antibodies.
Chromatin ImmunoprecipitationThis was performed essentially as described (22) on 107 BMEL cells transfected with the Flag/HNF-6 expression vector. DNA-protein complexes were cross-linked by addition of formaldehyde to the culture medium (final concentration 1%). After 10 min at room temperature, the cross-linking reaction was stopped by addition of glycine (final concentration 0.125 M) for 5 min. Cells were washed and harvested by scraping into phosphate-buffered saline containing 0.5 mM phenylmethylsulfonyl fluoride. The cells were lyzed in a buffer containing 10 mM Tris-Cl, pH 8.0, 85 mM KCl, 0.5% IGEPAL CA-630, 0.5 mM phenylmethylsulfonyl fluoride and protease inhibitors, and nuclei were collected. Nuclei were lyzed in a buffer containing 50 mM Tris-Cl, pH 8.0, 10 mM EDTA, 1% SDS, 0.5 mM phenylmethylsulfonyl fluoride and protease inhibitors, and were sonicated to produce DNA fragments of
200 to 1000 bp in length. The samples were centrifuged to eliminate cell debris, and DNA-protein complexes were precleared with salmon sperm DNA/protein A-agarose (Upstate) for 15 min at 4 °C with rotation. Each sample was then diluted with 0.01% SDS, 1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-Cl, pH 8.0, 167 mM NaCl, an aliquot was removed as "input" control, and the remaining sample was divided into two aliquots. M2 (anti-FLAG; Sigma) antibody was added to one aliquot, and anti-tubulin (Sigma) antibody was added to the second aliquot as a nonspecific antibody control. Samples were incubated with antibody overnight with rotation at 4 °C. The following day, salmon sperm DNA/protein A-agarose beads were added to the samples and incubated for 12 h at 4 °C with rotation to collect DNA-protein-antibody complexes. Beads were washed and DNA-protein complexes were eluted by two successive incubations at 65 °C for 10 min with freshly prepared elution buffer (1% SDS, 50 mM NaHCO3). NaCl (final concentration, 0.3 M) and RNase A were added to the eluted and input samples and incubated at 65 °C for 46 h to revert cross-links. Samples were precipitated overnight at -20 °C by addition of 2.5 volumes of 100% ethanol, resuspended in proteinase K buffer (10 mM Tris-Cl, pH 7.5, 5 mM EDTA, 0.25% SDS), and treated with proteinase K for 2 h at 45 °C. After this, DNA was purified by phenol/chloroform and chloroform extraction followed by ethanol precipitation. PCR was performed on 1/50th of the immunoprecipitated chromatin.
Whole Embryo Culture and ElectroporationWhole embryo culture and electroporation have been described in detail.2 Briefly, intact e8.5 embryos were incubated in a DNA solution and placed between the electrodes. Electroporation was performed using a square-wave pulse generator (Electro Square Porator ECM 830, BTX). After electroporation, embryos were cultured for 24 h at 37 °C in a roller culture system (31 rpm). Electroporated embryos developed normally and were further dissected for RNA extraction or processed for paraffin embedding, as for normal e9.5 embryos.
| RESULTS |
|---|
|
|
|---|
|
|
OC-3 Is Colocalized with HNF-6As a first step to investigate whether HNF6 exerts a direct control on Oc3 gene expression, we verified if the two factors are coexpressed. Sections from 19-somite embryos were examined by immunofluorescence using antibodies directed against HNF-6 and OC-3. To localize the endodermal epithelium and to distinguish it from the surrounding nonepithelial tissues, we used an antibody against E-cadherin, which is a component of the adherens junction complex between epithelial cells. As shown in Fig. 2A, HNF-6 nuclear staining was observed in all the endodermal cells in this region. Two adjacent sections stained with the anti-OC-3 antibody revealed nuclear OC-3 expression in cells on the ventral side of the endoderm (Fig. 2, B and C). As nuclei in this region were also positive for HNF-6 (Fig. 2A), we conclude that part of the cell population that expresses HNF-6 also expresses OC-3. To identify the cell types that express OC-3, these sections were costained with antibodies directed against Pdx-1, which labels pancreatic precursors (Fig. 2B), and Prox1, which labels hepatic precursors (23) (Fig. 2C). OC-3 was widely expressed in part of the ventral prepancreatic region as well as in the prehepatic region. At this stage, OC-3 was not detected in other regions of the endoderm. Thus, around e9.5, OC-3 is expressed in the ventral prepancreatic and prehepatic regions, a territory of the endoderm that also express HNF-6. One day later (32-somite stage), we performed immunohistochemistry for HNF-6 and OC-3, to better identify the developing organs in which they are expressed. HNF-6 protein was detected in the migrating hepatoblasts, gallbladder primordium, ventral and dorsal pancreas, stomach, and duodenum (Fig. 2D). OC-3 protein colocalized with HNF-6 in the migrating hepatoblasts, gallbladder primordium, ventral and dorsal pancreas as well as in some cells of the stomach and duodenum (Fig. 2E). This indicates that OC-3 is expressed in discrete regions of the endoderm were HNF-6 is present.
|
|
HNF-6 Induces Oc3 Gene Expression in the Developing EndodermWe then designed experiments to confirm that HNF-6 can stimulate Oc3 gene transcription in the mouse endoderm. We recently developed a system that allows delivery of DNA to discrete regions of the mouse endoderm in situ such as the prepancreatic or prehepatic territories.2 Electroporation of precisely oriented 6- to 8-somite embryos is followed by a 24-h culture of the whole embryos such that they reach the 1822-somite stage (Fig. 4A). Morphogenic events occur as they do in vivo during that period and the sheet of cells that forms the endoderm gives rise to the primitive gut. Using this technique we delivered a HNF-6 expression vector in the foregut-midgut region of the endoderm of e8.5 embryos, together with a GFP expression vector to assess electroporation efficiency. Nonelectroporated embryos were cultured in parallel as controls. After the 24-h culture, the region of the primitive gut corresponding to the targeted region was dissected out and total RNA was extracted and reverse transcribed. Fig. 4B shows that the electroporated embryos expressed Gfp and that Hnf6 was expressed in the endoderm electroporated with the HNF-6 expression vector. Expression levels of the endogenous Onecut genes in the endoderm of these embryos were measured by real time PCR. Endogenous Hnf6 mRNA was detected by using an antisense primer in the 3'-untranslated region of Hnf6, which is not present in the HNF-6 expression vector. As shown in Fig. 4C, the levels of Onecut factor mRNAs were not influenced by the electroporation per se. Expression of exogenous HNF-6 had no effect on Hnf6 or Oc2 expression. In contrast, it increased dramatically Oc3 expression in the endoderm.
|
|
| DISCUSSION |
|---|
|
|
|---|
expression in liver, thereby controlling intrahepatic bile duct morphogenesis (16), and in the pancreas HNF-6 stimulates expression of Hnf1
(24) and Ngn3 (15), thereby controlling endocrine differentiation. HNF-6 also plays a role at an earlier stage in the endoderm where it is involved in the onset of Pdx1 expression (14). In this paper, we identify a second transcription factor as an HNF-6 target in developing endoderm, namely its paralog OC-3. Indeed, we show here that HNF-6 can bind to the Oc3 gene in native chromatin and that it can stimulate Oc3 expression not only in transfected cells, but also in the endoderm in situ. Moreover, this regulatory cascade is developmentally relevant, as inactivation of the Hnf6 gene leads to a down-regulation of OC-3 both in the endoderm and in the endoderm-derived organs that express HNF-6, namely the liver and pancreas. It is noteworthy that induction of Oc3 expression by HNF-6 is limited in time and space. At e9, expression of OC3 in the endoderm is detected only in a subpopulation of HNF-6-expressing cells, whereas at e10.5 OC-3 expression extends to almost all the HNF-6 territory, which corresponds to the liver, pancreas, and part of the stomach and gut. Later on, HNF-6 becomes restricted to the liver and the pancreas, whereas OC-3 disappears from these tissues but remains expressed in the stomach and in the intestine (1012). The induction of Oc3 by HNF-6 may require time and space-restricted cooperation of HNF-6 with other Oc3 regulatory factors and/or posttranslational regulation of HNF-6 activity (25).
We also show here that all three Onecut factors are expressed in a region of the endoderm that will eventually form the stomach, duodenum, liver, and pancreas. Interestingly, they are expressed in the sequential order Hnf6, Oc2, Oc3, so that Onecut factor expression defines three successive steps in endoderm maturation (Fig. 6A). This is relevant for understanding pancreas and liver development and for implementing this information in the context of cell therapy. Indeed, transcription factors alone or in combination are used to promote controlled cell differentiation and are useful markers to determine the precise differentiation stages of cells that are cultured in well defined conditions.
|
Another implication of the present work bears on the interpretation of the endodermal phenotype of Hnf6 knock-out embryos. Pdx-1 expression in their endoderm is retarded from the 812-somite stage until the 1922-somite stage (14), i.e. Pdx-1 appears at the time when OC-3 becomes significantly expressed in the normal embryo. This could have suggested that it is OC-3 that triggers Pdx-1 expression in the absence of HNF-6. Our data show that this is unlikely, as in the Hnf6 knock-out Pdx-1 eventually appears despite the absence of OC-3. The question of the possible role of OC-2 in inducing Pdx-1 in the Hnf6 knock-out embryos remains open, because OC-2 levels are unaffected in these knock-out embryos. On the other hand, the fact that OC-3 is down-regulated in the Hnf6 knock-out embryos may account for some developmental defects of these embryos. These defects might result from failed expression of genes that are targeted specifically by OC-3 alone or by both HNF-6 and OC-3. Because, in normal embryos, OC-3 is first detected on the ventral side (prehepatic and prepancreatic territories) of the endoderm, one would expect that the consequences of this combined HNF-6/OC-3 deficiency appear first in the ventral prepancreatic and/or prehepatic endoderm. This is indeed the case. In Hnf6 knock-out embryos, development is more severely affected on the ventral side than on the dorsal side, with an absence of gallbladder, a longer delay in the expression of Pdx-1, and an extremely reduced ventral pancreatic bud (14, 16).
Earlier experiments with cultured cells and on Hnf6 knock-out embryos have shown that HNF-6 can bind to and stimulate several genes coding for transcription factors. Thus, HNF-6 participates to the networks of transcription factors that regulate development of the endoderm and endoderm-derived organs. These factors include HNF-3
, HNF-4, HNF-1
, Pdx-1, and Ngn3. The present work extends our knowledge of the control exerted on these factors, not only by HNF-6, but also by the other Onecut proteins (Fig. 6B). In the endoderm, HNF-6 is required for normal expression of Pdx1 (14), Oc3 (this paper), and Hnf1
,3 but not for that of Hnf3
(14) or Hnf4. In the liver, HNF-6 is critical for expression of Oc3 (this paper) and Hnf1
, and this HNF-6
Hnf1
cascade controls bile duct development (16). Whereas independent inactivation of Hnf6 or Oc2 does not affect Hnf4 expression in liver, the combined inactivation of Hnf6 and Oc2 strongly reduces expression of the
7 isoform of HNF-4 (26). The expression of Hnf3
is also controlled by HNF-6 in the liver, but via an inhibitory, transforming growth factor
-dependent mechanism (27). In the pancreas, HNF-6 is required for Oc3 expression (this paper) and HNF-6 controls Hnf1
(24) and Ngn3 (15) expression during endocrine differentiation. Although no OC-3 target genes have been identified to date, this factor may be involved in the differentiation of the endoderm and endoderm-derived tissues, downstream of HNF-6.
In conclusion, the data presented here broaden our understanding of the network of transcription factors that are expressed in the endoderm. They define stages in the embryonic expression pattern of the Onecut transcription factors. They identify OC-3 as a new target of HNF-6 in the endoderm as well as in developing pancreas and liver, pointing to a new mechanism by which HNF-6 can control developmental events.
| FOOTNOTES |
|---|
Supported by a fellowship from the Fonds pour la Formation à la Recherche dans l'Industrie et dans l'Agriculture. ![]()
¶ Research Associate of the Fonds National de la Recherche Scientifique. ![]()
To whom correspondence should be addressed: HORM Unit, ICP-UCL Box 7529, 75 Avenue Hippocrate, B-1200 Brussels, Belgium. Tel.: 32-2-764-7524; Fax: 32-2-764-7507; E-mail: christophe.pierreux{at}horm.ucl.ac.be.
1 The abbreviations used are: HNF, hepatocyte nuclear factor; OC, Onecut; e, embryonic day; GFP, green fluorescent protein; BMEL, bipotential mouse embryonic liver; CMV, cytomegalovirus. ![]()
2 C. E. Pierreux, A. V. Poll, P. Jacquemin, F. P. Lemaigre, and G. G. Rousseau, submitted for publication. ![]()
3 C. E. Pierreux, F. P. Lemaigre, and G. G. Rousseau, unpublished observations. ![]()
| ACKNOWLEDGMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. Thangavel and B. H. Shapiro Inherent Sexually Dimorphic Expression of Hepatic CYP2C12 Correlated with Repressed Activation of Growth Hormone-Regulated Signal Transduction in Male Rats Drug Metab. Dispos., September 1, 2008; 36(9): 1884 - 1895. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Maier, M. R. Dusing, and D. A. Wiginton Temporal Regulation of Enhancer Function in Intestinal Epithelium: A ROLE FOR ONECUT FACTORS J. Biol. Chem., October 27, 2006; 281(43): 32263 - 32271. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-B. Beaudry, C. E. Pierreux, G. P. Hayhurst, N. Plumb-Rudewiez, M. C. Weiss, G. G. Rousseau, and F. P. Lemaigre Threshold Levels of Hepatocyte Nuclear Factor 6 (HNF-6) Acting in Synergy with HNF-4 and PGC-1{alpha} Are Required for Time-Specific Gene Expression during Liver Development. Mol. Cell. Biol., August 1, 2006; 26(16): 6037 - 6046. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Poll, C. E. Pierreux, L. Lokmane, C. Haumaitre, Y. Achouri, P. Jacquemin, G. G. Rousseau, S. Cereghini, and F. P. Lemaigre A vHNF1/TCF2-HNF6 Cascade Regulates the Transcription Factor Network That Controls Generation of Pancreatic Precursor Cells Diabetes, January 1, 2006; 55(1): 61 - 69. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE |